AAAAAA

   
Results: 1-18 |
Results: 18
COMPARISON OF THE SHORT-TERM EFFECTS OF 3 ORAL CALCIUM-VITAMIN-D FORMULATIONS AND PLACEBO ON CALCIUM-METABOLISM
Authors: DEROISY R COLLETTE J ALBERT A LEBER C MICHELETTI MC ZARTARIAN M REGINSTER JY
Citation: R. Deroisy et al., COMPARISON OF THE SHORT-TERM EFFECTS OF 3 ORAL CALCIUM-VITAMIN-D FORMULATIONS AND PLACEBO ON CALCIUM-METABOLISM, Current therapeutic research, 59(6), 1998, pp. 370-378
ACUTE CHANGES IN SERUM-CALCIUM AND PARATHYROID-HORMONE CIRCULATING LEVELS INDUCED BY THE ORAL INTAKE OF 5 CURRENTLY AVAILABLE CALCIUM SALTSIN HEALTHY MALE-VOLUNTEERS
Authors: DEROISY R ZARTARIAN M MEURMANS L NELISSENNE N MICHELETTI MC ALBERT A REGINSTER JY
Citation: R. Deroisy et al., ACUTE CHANGES IN SERUM-CALCIUM AND PARATHYROID-HORMONE CIRCULATING LEVELS INDUCED BY THE ORAL INTAKE OF 5 CURRENTLY AVAILABLE CALCIUM SALTSIN HEALTHY MALE-VOLUNTEERS, Clinical rheumatology, 16(3), 1997, pp. 249-253
PLASMA ESTRADIOL CONCENTRATIONS AND PHARMACOKINETICS FOLLOWING TRANSDERMAL APPLICATION OF MENOREST(R)-50 OR SYSTEN(R)-(EVOREL(R))-50 (VOL 27, PG 179, 1997)
Authors: REGINSTER JY ALBERT A DEROISY R COLETTE J VRIJENS B BLACKER C BRION N CAULIN F MAYOLLE C REGNARD A SCHOLLER R FRANCHIMONT P
Citation: Jy. Reginster et al., PLASMA ESTRADIOL CONCENTRATIONS AND PHARMACOKINETICS FOLLOWING TRANSDERMAL APPLICATION OF MENOREST(R)-50 OR SYSTEN(R)-(EVOREL(R))-50 (VOL 27, PG 179, 1997), Maturitas, 28(2), 1997, pp. 193-195
PLASMA ESTRADIOL CONCENTRATIONS AND PHARMACOKINETICS FOLLOWING TRANSDERMAL APPLICATION OF MENOREST(R)-50 OR SYSTEN(R) (EVOREL(R))-50
Authors: REGINSTER JY ALBERT A DEROISY R COLETTE J VRIJENS B BLACKER C BRION N CAULIN F MAYOLLE C REGNARD A SCHOLLER R FRANCHIMONT P
Citation: Jy. Reginster et al., PLASMA ESTRADIOL CONCENTRATIONS AND PHARMACOKINETICS FOLLOWING TRANSDERMAL APPLICATION OF MENOREST(R)-50 OR SYSTEN(R) (EVOREL(R))-50, Maturitas, 27(2), 1997, pp. 179-186
PREDICTION OF BONE LOSS RATE IN HEALTHY POSTMENOPAUSAL WOMEN
Authors: REGINSTER JY DEROISY R COLLETTE J ALBERT A ZEGELS B
Citation: Jy. Reginster et al., PREDICTION OF BONE LOSS RATE IN HEALTHY POSTMENOPAUSAL WOMEN, Calcified tissue international, 60(3), 1997, pp. 261-264
THE ROLE OF BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS
Authors: REGINSTER JYL HALKIN V GOSSET C DEROISY R
Citation: Jyl. Reginster et al., THE ROLE OF BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS, Medicamentos de actualidad, 33(8), 1997, pp. 563-570
FEMORAL BONE-DENSITY AND VITAMIN-D DEFICIENCY IN ELDERLY WOMEN
Authors: DEROISY R PIRENNE H FREDERICK I ZEGELS B TAQUET AN NOEL V ZHENG ZX REGINSTER JY
Citation: R. Deroisy et al., FEMORAL BONE-DENSITY AND VITAMIN-D DEFICIENCY IN ELDERLY WOMEN, Journal of bone and mineral research, 10, 1995, pp. 463-463
LONG-TERM PERFORMANCE IN-VITRO AND IN-VIVO OF DUAL-ENERGY X-RAY ABSORPTIOMETRY
Authors: REGINSTER JY DEROISY R ZEGELS B JUPSIN I ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., LONG-TERM PERFORMANCE IN-VITRO AND IN-VIVO OF DUAL-ENERGY X-RAY ABSORPTIOMETRY, Clinical rheumatology, 14(2), 1995, pp. 180-186
BONE-MINERAL DENSITY OF THE SPINE AND THE HIP MEASURED WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY - NORMAL RANGE AND FRACTURE THRESHOLD FOR WESTERN-EUROPEAN (BELGIAN) POSTMENOPAUSAL FEMALES
Authors: REGINSTER JY JANSSEN C DEROISY R ZEGELS B ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., BONE-MINERAL DENSITY OF THE SPINE AND THE HIP MEASURED WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY - NORMAL RANGE AND FRACTURE THRESHOLD FOR WESTERN-EUROPEAN (BELGIAN) POSTMENOPAUSAL FEMALES, Clinical rheumatology, 14(1), 1995, pp. 68-75
PREVENTION OF POSTMENOPAUSAL BONE LOSS BY RECTAL CALCITONIN
Authors: REGINSTER JY JUPSIN I DEROISY R BIQUET I FRANCHIMONT N FRANCHIMONT P
Citation: Jy. Reginster et al., PREVENTION OF POSTMENOPAUSAL BONE LOSS BY RECTAL CALCITONIN, Calcified tissue international, 56(6), 1995, pp. 539-542
A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF INTERMITTENT NASAL SALMON-CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL LUMBAR SPINE BONE LOSS
Authors: REGINSTER JY DEROISY R LECART MP SARLET N ZEGELS B JUPSIN I DELONGUEVILLE M FRANCHIMONT P
Citation: Jy. Reginster et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF INTERMITTENT NASAL SALMON-CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL LUMBAR SPINE BONE LOSS, The American journal of medicine, 98(5), 1995, pp. 452-458
LONG-TERM (3 YEARS) PREVENTION OF TRABECULAR POSTMENOPAUSAL BONE LOSSWITH LOW-DOSE INTERMITTENT NASAL SALMON-CALCITONIN
Authors: REGINSTER JY DENIS D DEROISY R LECART MP DELONGUEVILLE M ZEGELS B SARLET N NOIRFALISSE P FRANCHIMONT P
Citation: Jy. Reginster et al., LONG-TERM (3 YEARS) PREVENTION OF TRABECULAR POSTMENOPAUSAL BONE LOSSWITH LOW-DOSE INTERMITTENT NASAL SALMON-CALCITONIN, Journal of bone and mineral research, 9(1), 1994, pp. 69-73
A 5-YEAR CONTROLLED RANDOMIZED STUDY OF PREVENTION OF POSTMENOPAUSAL TRABECULAR BONE LOSS WITH NASAL SALMON-CALCITONIN AND CALCIUM
Authors: REGINSTER JY MEURMANS L DEROISY R JUPSIN I BIQUET I ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., A 5-YEAR CONTROLLED RANDOMIZED STUDY OF PREVENTION OF POSTMENOPAUSAL TRABECULAR BONE LOSS WITH NASAL SALMON-CALCITONIN AND CALCIUM, European journal of clinical investigation, 24(8), 1994, pp. 565-569
PREVENTION OF OSTEOPOROSIS WITH NASAL SALMON-CALCITONIN - EFFECT OF ANTI-SALMON CALCITONIN ANTIBODY-FORMATION
Authors: REGINSTER JY GASPAR S DEROISY R ZEGELS B FRANCHIMONT P
Citation: Jy. Reginster et al., PREVENTION OF OSTEOPOROSIS WITH NASAL SALMON-CALCITONIN - EFFECT OF ANTI-SALMON CALCITONIN ANTIBODY-FORMATION, Osteoporosis international, 3(5), 1993, pp. 261-264
ACUTE BIOCHEMICAL VARIATIONS INDUCED BY 4 DIFFERENT CALCIUM SALTS IN HEALTHY MALE-VOLUNTEERS
Authors: REGINSTER JY DENIS D BARTSCH V DEROISY R ZEGELS B FRANCHIMONT P
Citation: Jy. Reginster et al., ACUTE BIOCHEMICAL VARIATIONS INDUCED BY 4 DIFFERENT CALCIUM SALTS IN HEALTHY MALE-VOLUNTEERS, Osteoporosis international, 3(5), 1993, pp. 271-275
NEW RADIOIMMUNOASSAY FOR DETERMINATION OF BONE SPECIFIC ISOENZYMES OFSERUM ALKALINE-PHOSPHATASES ACTIVITY (OSTASE-DEGREES) - VALIDATION AND CLINICAL PERSPECTIVE
Authors: REGINSTER JY MEURMANS L ZEGELS B DARTE C COLLETTE J DEROISY R FRANCHIMONT P
Citation: Jy. Reginster et al., NEW RADIOIMMUNOASSAY FOR DETERMINATION OF BONE SPECIFIC ISOENZYMES OFSERUM ALKALINE-PHOSPHATASES ACTIVITY (OSTASE-DEGREES) - VALIDATION AND CLINICAL PERSPECTIVE, Journal of bone and mineral research, 8, 1993, pp. 190000261-190000261
NASAL SALMON-CALCITONIN FOR PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS - A DOSE-RANGING PLACEBO-CONTROLLED STUDY
Authors: REGINSTER JY DEROISY R LECART MP ZEGELS B SARLET N DELONGUEVILLE M ALBERT A FRANCHIMONT P
Citation: Jy. Reginster et al., NASAL SALMON-CALCITONIN FOR PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS - A DOSE-RANGING PLACEBO-CONTROLLED STUDY, Journal of bone and mineral research, 8, 1993, pp. 190000340-190000340
EFFECT OF TRANSDERMAL 17-BETA-ESTRADIOL AND ORAL CONJUGATED EQUINE ESTROGENS ON BIOCHEMICAL PARAMETERS OF BONE-RESORPTION IN NATURAL MENOPAUSE
Authors: REGINSTER JY CHRISTIANSEN C DEQUINZE B DEROISY R GASPARD U TAQUET AN FRANCHIMONT P
Citation: Jy. Reginster et al., EFFECT OF TRANSDERMAL 17-BETA-ESTRADIOL AND ORAL CONJUGATED EQUINE ESTROGENS ON BIOCHEMICAL PARAMETERS OF BONE-RESORPTION IN NATURAL MENOPAUSE, Calcified tissue international, 53(1), 1993, pp. 13-16
Risultati: 1-18 |